The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Hydrocephalus 1
SANDOSTATIN LAR DEPOT Hyperchlorhydria 1
SANDOSTATIN LAR DEPOT Hypercoagulation 1
SANDOSTATIN LAR DEPOT Hyperlipidaemia 1
SANDOSTATIN LAR DEPOT Hypertonic bladder 1
SANDOSTATIN LAR DEPOT Hypertrichosis 1
SANDOSTATIN LAR DEPOT Hypocalcaemia 1
SANDOSTATIN LAR DEPOT Hypotonia 1
SANDOSTATIN LAR DEPOT Immobile 1
SANDOSTATIN LAR DEPOT Impaired insulin secretion 1
SANDOSTATIN LAR DEPOT Incision site infection 1
SANDOSTATIN LAR DEPOT Incoherent 1
SANDOSTATIN LAR DEPOT Infected cyst 1
SANDOSTATIN LAR DEPOT Infected skin ulcer 1
SANDOSTATIN LAR DEPOT Injection site discharge 1
SANDOSTATIN LAR DEPOT Injection site eczema 1
SANDOSTATIN LAR DEPOT Injection site hyperaesthesia 1
SANDOSTATIN LAR DEPOT Injection site hypoaesthesia 1
SANDOSTATIN LAR DEPOT Injection site nerve damage 1
SANDOSTATIN LAR DEPOT Injection site pustule 1

Total Records: 2,045     Number of Pages: 103